Johnson & Johnson Results: A Deep Dive into Q3 2024 Earnings
Overview of Johnson & Johnson Q3 2024 Earnings
Johnson & Johnson (NYSE: JNJ) reported its Q3 2024 earnings today. Highlighting a 5.2% year-over-year increase in sales, total revenue reached $22.5 billion. Nevertheless, there was a striking 37.5% decrease in GAAP earnings to $2.7 billion, with EPS falling 34% to $1.11.
Sales and Financial Expectations
Adjusted EPS showed a 9% decline to $2.42. Looking ahead, the firm expects reported sales for the full year 2024 to range between $88.4 billion to $88.8 billion, with adjusted EPS projected at $9.88 to $9.98.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.